{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:21:42Z","timestamp":1793715702637,"version":"4.6.1"},"reference-count":165,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bja.2025.04.001","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T23:38:08Z","timestamp":1747352288000},"page":"48-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3369-382X","authenticated-orcid":false,"given":"Adriana D.","family":"Oprea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7288-2039","authenticated-orcid":false,"given":"Laura J.","family":"Ostapenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7497-0614","authenticated-orcid":false,"given":"BobbieJean","family":"Sweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2241-010X","authenticated-orcid":false,"given":"Angela","family":"Selzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4078-6805","authenticated-orcid":false,"given":"Joan M.","family":"Irizarry-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Hurtado Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1875-6124","authenticated-orcid":false,"given":"Carlos E.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen D.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia R.","family":"Fernandez Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-7514","authenticated-orcid":false,"given":"Michael","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1053-6557","authenticated-orcid":false,"given":"Ruchi","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Hepner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2025.04.001_bib1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/dom.14988","volume":"25","author":"Nauck","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029282","article-title":"Role of glucagon-like peptide-1 receptor agonists in achieving weight loss and improving cardiovascular outcomes in people with overweight and obesity","volume":"12","author":"Michos","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.bja.2025.04.001_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/23969873241234238","article-title":"Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP\/GLP-1 receptor agonist tirzepatide for type 2 diabetes: a systematic review and meta-analysis","volume":"9","author":"Stefanou","year":"2024","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.bja.2025.04.001_bib4","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc24-S009","article-title":"Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bja.2025.04.001_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.eprac.2023.02.001","article-title":"American Association of Clinical Endocrinology consensus statement: comprehensive type 2 diabetes management algorithm - 2023 update","volume":"29","author":"Samson","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/j.bja.2025.04.001_bib6","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bja.2025.04.001_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102403","article-title":"Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patients","volume":"49","author":"Singh","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.bja.2025.04.001_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/jcpt.13225","article-title":"Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes","volume":"45","author":"Trujillo","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.bja.2025.04.001_bib9","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2023.19574","article-title":"Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss","volume":"330","author":"Sodhi","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2025.04.001_bib10","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s11695-018-3249-1","article-title":"Liraglutide effects on upper gastrointestinal investigations: implications prior to bariatric surgery","volume":"28","author":"Modi","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.bja.2025.04.001_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12630-024-02761-x","article-title":"Rates of glucagon-like peptide-1 receptor agonist use and aspiration events associated with anesthesia at a Canadian academic teaching centre","volume":"71","author":"Milne","year":"2024","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2025.04.001_bib12","article-title":"Medication-induced gastroparesis: a case report","volume":"9","author":"Kalas","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.bja.2025.04.001_bib13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.cgh.2023.11.024","article-title":"Low incidence of pulmonary aspiration during upper endoscopy in patients prescribed a glucagon-like peptide 1 receptor agonist","volume":"22","author":"Anazco","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bja.2025.04.001_bib14","article-title":"Gastroparesis with the initiation of liraglutide: a case report","volume":"12","author":"Almustanyir","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.bja.2025.04.001_bib15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12630-023-02521-3","article-title":"Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report","volume":"70","author":"Gulak","year":"2023","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2025.04.001_bib16","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s12630-023-02440-3","article-title":"Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report","volume":"70","author":"Klein","year":"2023","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2025.04.001_bib17","article-title":"Anesthesia considerations for a patient on semaglutide and delayed gastric emptying","volume":"15","author":"Fujino","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.bja.2025.04.001_bib18","article-title":"Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss","volume":"12","author":"Avraham","year":"2024","journal-title":"Anaesth Rep"},{"key":"10.1016\/j.bja.2025.04.001_bib19","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.CC.23.00506","article-title":"Retained gastric contents after adequate fasting associated with GLP-1 receptor agonist use: a report of 3 cases","volume":"13","author":"Kittner","year":"2023","journal-title":"JBJS Case Connect"},{"key":"10.1016\/j.bja.2025.04.001_bib20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/10600280211055804","article-title":"Impact of glucagon-like peptide-1 receptor agonists (GLP-1RA) on food content during esophagogastroduodenoscopy (EGD)","volume":"56","author":"Stark","year":"2022","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.bja.2025.04.001_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira","year":"2023","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.bja.2025.04.001_bib22","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12630-023-02549-5","article-title":"Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide","volume":"70","author":"Sherwin","year":"2023","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2025.04.001_bib23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/jdi.14005","article-title":"Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy","volume":"14","author":"Kobori","year":"2023","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.bja.2025.04.001_bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.gie.2024.04.2900","article-title":"Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and non-diabetic patients","volume":"100","author":"Nadeem","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bja.2025.04.001_bib25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cgh.2024.03.013","article-title":"Clinical outcomes and safety of upper endoscopy while on glucagon-like peptide-1 receptor agonists","volume":"23","author":"Firkins","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bja.2025.04.001_bib26","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.14309\/ajg.0000000000002777","article-title":"Glucagon-like peptide-1 receptor agonists increase solid gastric residue rates on upper endoscopy especially in patients with complicated diabetes: a case-control study","volume":"119","author":"Garza","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bja.2025.04.001_bib27","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s12630-024-02719-z","article-title":"Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study","volume":"71","author":"Wu","year":"2024","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2025.04.001_bib28","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.2024.5003","article-title":"Preoperative GLP-1 receptor agonist use and risk of postoperative respiratory complications","volume":"331","author":"Dixit","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2025.04.001_bib29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg"},{"key":"10.1016\/j.bja.2025.04.001_bib30","article-title":"Point-of-care gastric ultrasound to identify a full stomach on a diabetic patient taking a glucagon-like peptide 1 receptor agonist","volume":"18","author":"Giron-Arango","year":"2024","journal-title":"A A Pract"},{"key":"10.1016\/j.bja.2025.04.001_bib31","article-title":"Point-of-care ultrasound aids in the management of patient taking semaglutide before surgery: a case report","volume":"18","author":"Hodgson","year":"2024","journal-title":"A A Pract"},{"key":"10.1016\/j.bja.2025.04.001_bib32","doi-asserted-by":"crossref","first-page":"eRC0628","DOI":"10.31744\/einstein_journal\/2023RC0628","article-title":"Risk of pulmonary aspiration during semaglutide use and anesthesia in a fasting patient: a case report with tomographic evidence","volume":"21","author":"Queiroz","year":"2023","journal-title":"Einstein (Sao Paulo)"},{"key":"10.1016\/j.bja.2025.04.001_bib33","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.amjmed.2023.07.016","article-title":"Delayed gastric emptying with perioperative use of glucagon-like peptide-1 receptor agonists","volume":"136","author":"Raven","year":"2023","journal-title":"Am J Med"},{"key":"10.1016\/j.bja.2025.04.001_bib34","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.bja.2023.05.005","article-title":"Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss","volume":"131","author":"Weber","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.04.001_bib35","article-title":"Particulate gastric contents in patients prescribed glucagon-like peptide 1 receptor agonists after appropriate perioperative fasting: a report of 2 cases","volume":"17","author":"Wilson","year":"2023","journal-title":"A A Pract"},{"key":"10.1016\/j.bja.2025.04.001_bib36","article-title":"Tendency of semaglutide to induce gastroparesis: a case report","volume":"16","author":"Chaudhry","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.bja.2025.04.001_bib37","article-title":"Suspected gastroparesis with concurrent gastroesophageal reflux disease induced by low-dose liraglutide","volume":"14","author":"Ishihara","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.bja.2025.04.001_bib38","article-title":"Liraglutide-induced acute gastroparesis","volume":"10","author":"Rai","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.bja.2025.04.001_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080340","article-title":"Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study","volume":"387","author":"Alkabbani","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2025.04.001_bib40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cgh.2024.04.038","article-title":"Glucagon-like peptide-1 receptor agonists do not increase aspiration during upper endoscopy in patients with diabetes","volume":"23","author":"Barlowe","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bja.2025.04.001_bib41","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.gie.2024.05.012","article-title":"Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during esophagogastroduodenoscopy","volume":"100","author":"Chapman","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bja.2025.04.001_bib42","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.3748\/wjg.v30.i26.3221","article-title":"Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study","volume":"30","author":"Ghazanfar","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bja.2025.04.001_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/jim-2022-002480","article-title":"Frequency of GLP-1 receptor agonists use in diabetic patients diagnosed with delayed gastric emptying and their demographic profile","volume":"71","author":"Kalas","year":"2023","journal-title":"J Investig Med"},{"key":"10.1016\/j.bja.2025.04.001_bib44","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1111\/dom.15636","article-title":"Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists","volume":"26","author":"Klonoff","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib45","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s11695-024-07278-2","article-title":"Safe Continuation of glucagon-like peptide 1 receptor agonists at endoscopy: a case series of 57 adults undergoing endoscopic sleeve gastroplasty","volume":"34","author":"Maselli","year":"2024","journal-title":"Obes Surg"},{"key":"10.1016\/j.bja.2025.04.001_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.36783","article-title":"Food retention at endoscopy among adults using glucagon-like peptide-1 receptor agonists","volume":"7","author":"Nasser","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.bja.2025.04.001_bib47","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/ALN.0000000000005174","article-title":"Association between glucagon-like peptide-1 receptor agonists and aspiration pneumonia during endoscopic procedures","volume":"141","author":"Peng","year":"2024","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.04.001_bib48","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.3390\/jcm13185403","article-title":"Real-world impact of GLP-1 receptor agonists on endoscopic patient outcomes in an ambulatory setting: a retrospective study at a large tertiary center","volume":"13","author":"Robalino Gonzaga","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.bja.2025.04.001_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2024.111668","article-title":"Effect of various perioperative semaglutide interruption intervals on residual gastric content assessed by esophagogastroduodenoscopy: a retrospective single center observational study","volume":"99","author":"Santos","year":"2024","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.bja.2025.04.001_bib50","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1111\/dom.15711","article-title":"No association between semaglutide and postoperative pneumonia in people with diabetes undergoing elective surgery","volume":"26","author":"Welk","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2024.03.015","article-title":"Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with glucagon-like peptide 1 receptor agonist use","volume":"167","author":"Yeo","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bja.2025.04.001_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrac169","article-title":"Gastroparesis with bezoar formation in patients treated with glucagon-like peptide-1 receptor agonists: potential relevance for bariatric and other gastric surgery","volume":"7","author":"Preda","year":"2023","journal-title":"BJS Open"},{"key":"10.1016\/j.bja.2025.04.001_bib53","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.soard.2024.08.039","article-title":"Evaluation of gastric content in fasting patient during semaglutide use: an observational study","volume":"21","author":"Queiroz","year":"2025","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.bja.2025.04.001_bib54","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/anae.16454","article-title":"Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study","volume":"79","author":"Nersessian","year":"2024","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bja.2025.04.001_bib55","author":"Joshi"},{"key":"10.1016\/j.bja.2025.04.001_bib56","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12630-024-02810-5","article-title":"Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations","volume":"71","author":"Chang","year":"2024","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2025.04.001_bib57","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.soard.2024.08.033","article-title":"Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"20","author":"Kindel","year":"2024","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.bja.2025.04.001_bib58","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/anae.16541","volume":"80","author":"El-Boghdadly","year":"2025","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bja.2025.04.001_bib59","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc22-Sint","article-title":"Introduction: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bja.2025.04.001_bib60","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5694\/mja2.52170","article-title":"Considerations of delayed gastric emptying with peri-operative use of glucagon-like peptide-1 receptor agonists","volume":"220","author":"Raven","year":"2024","journal-title":"Med J Aust"},{"key":"10.1016\/j.bja.2025.04.001_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjao.2024.100282","article-title":"Preoperative fasting and the risk of pulmonary aspiration-a narrative review of historical concepts, physiological effects, and new perspectives","volume":"10","author":"R\u00fcggeberg","year":"2024","journal-title":"BJA Open"},{"key":"10.1016\/j.bja.2025.04.001_bib62","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.gie.2024.10.011","article-title":"Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes: a systematic review & meta-analysis","volume":"101","author":"Singh","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bja.2025.04.001_bib63","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cgh.2024.07.021","article-title":"Effects of glucagon-like peptide-1 receptor agonists on upper gastrointestinal endoscopy: a meta-analysis","volume":"23","author":"Facciorusso","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bja.2025.04.001_bib64","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/jcm9030673","article-title":"Effects of liraglutide on myocardial function after cardiac surgery: a secondary analysis of the randomised controlled GLOBE trial","volume":"9","author":"Hulst","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.bja.2025.04.001_bib65","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/dom.13029","article-title":"Effect of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: a single-blind, randomized controlled trial","volume":"19","author":"Lip\u0161","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib66","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/dme.14084","article-title":"Addition of low-dose liraglutide to insulin therapy is useful for glycaemic control during the peri-operative period: effect of glucagon-like peptide-1 receptor agonist therapy on glycaemic control in patients undergoing cardiac surgery (GLOLIA study)","volume":"36","author":"Makino","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/j.bja.2025.04.001_bib67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/aca.aca_214_20","article-title":"Comparison of glucose control by added liraglutide to only insulin infusion in diabetic patient undergoing cardiac surgery: a preliminary randomized-controlled trial","volume":"26","author":"Sindhvananda","year":"2023","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.bja.2025.04.001_bib68","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/anae.14180","article-title":"Peri-operative management of patients with type-2 diabetes mellitus undergoing non-cardiac surgery using liraglutide, glucose-insulin-potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial","volume":"73","author":"Polderman","year":"2018","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bja.2025.04.001_bib69","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1053\/j.jvca.2024.06.015","article-title":"Continuous glucose monitoring and the effect of liraglutide in cardiac surgery patients: a substudy of the randomized controlled GLOBE trial","volume":"38","author":"Oosterom-Eijmael","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2025.04.001_bib70","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/dom.13927","article-title":"Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial","volume":"22","author":"Hulst","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib71","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2217\/fca-2022-0093","article-title":"Effect of glucagon-like peptide-1 receptor agonists administration during coronary artery bypass grafting: a systematic review and meta-analysis of randomized control trials","volume":"19","author":"Watkins","year":"2023","journal-title":"Future Cardiol"},{"key":"10.1016\/j.bja.2025.04.001_bib72","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/ALN.0000000000001838","article-title":"Clinical effectiveness of intravenous exenatide infusion in perioperative glycemic control after coronary artery bypass graft surgery: a phase II\/III randomized trial","volume":"127","author":"Besch","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.04.001_bib73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijcard.2015.12.009","article-title":"Effects of liraglutide on no-reflow in patients with acute ST-segment elevation myocardial infarction","volume":"208","author":"Chen","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.bja.2025.04.001_bib74","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.1007\/s00464-023-10387-1","article-title":"Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study","volume":"37","author":"Ilanga","year":"2023","journal-title":"Surg Endosc"},{"key":"10.1016\/j.bja.2025.04.001_bib75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000494768","article-title":"GLP1 receptor agonist liraglutide is an effective therapeutic option for perioperative glycemic control in type 2 diabetes within Enhanced Recovery after Surgery (ERAS) protocols","volume":"59","author":"Kaneko","year":"2018","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.bja.2025.04.001_bib76","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.bja.2025.04.001_bib77","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.arth.2023.12.023","article-title":"Semaglutide use prior to total hip arthroplasty results in fewer postoperative prosthetic joint infections and readmissions","volume":"39","author":"Magruder","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.bja.2025.04.001_bib78","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.arth.2024.05.079","article-title":"Decreased risk of readmission and complications with preoperative glp-1 analog use in patients undergoing primary total joint arthroplasty","volume":"39","author":"Buddhiraju","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.bja.2025.04.001_bib79","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12933-018-0784-y","article-title":"Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II\/III ExSTRESS randomized trial","volume":"17","author":"Besch","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.bja.2025.04.001_bib80","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ahj.2015.07.014","article-title":"Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"170","author":"Chen","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.bja.2025.04.001_bib81","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1210\/clinem\/dgac278","article-title":"Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society Clinical Practice Guideline","volume":"107","author":"Korytkowski","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib82","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/ALN.0b013e3181d3d4b4","article-title":"Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery","volume":"112","author":"Duncan","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.04.001_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.107.706416","article-title":"Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery","volume":"118","author":"Ascione","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bja.2025.04.001_bib84","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019216","article-title":"Associations between preoperative glucose and hemoglobin a1c level and myocardial injury after noncardiac surgery","volume":"10","author":"Park","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.bja.2025.04.001_bib85","first-page":"32","article-title":"Association between preoperative glucose dysregulation and delirium after non-cardiac surgery","volume":"13","author":"Oh","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.bja.2025.04.001_bib86","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0016-5085(97)70080-5","article-title":"Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus","volume":"113","author":"Schvarcz","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bja.2025.04.001_bib87","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/psp4.13099","article-title":"Population pharmacokinetics of the GIP\/GLP receptor agonist tirzepatide","volume":"13","author":"Schneck","year":"2024","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.bja.2025.04.001_bib88","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s40262-015-0343-6","article-title":"Liraglutide in type 2 diabetes mellitus: clinical pharmacokinetics and pharmacodynamics","volume":"55","author":"Jacobsen","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2025.04.001_bib89","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s13300-018-0458-5","article-title":"Semaglutide s.c. once-weekly in type 2 diabetes: a population pharmacokinetic analysis","volume":"9","author":"Carlsson Petri","year":"2018","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.bja.2025.04.001_bib90","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40262-015-0338-3","article-title":"Clinical pharmacokinetics of dulaglutide in patients with type 2 diabetes: analyses of data from clinical trials","volume":"55","author":"Geiser","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2025.04.001_bib91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/5584_2020_496","article-title":"Effects of GLP-1 and its analogs on gastric physiology in diabetes mellitus and obesity","volume":"1307","author":"Maselli","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bja.2025.04.001_bib92","doi-asserted-by":"crossref","unstructured":"Umpierrez G, Pasquel FJ, Duggan E, Galindo RJ. Should we stop glucagon-like peptide-1 receptor agonists before surgical or endoscopic procedures? Balancing limited evidence with clinical judgment. J Diabetes Sci Technol Advance Access published on Mar 11, 2024, doi: 10.1177\/19322968241231565.","DOI":"10.1177\/19322968241231565"},{"key":"10.1016\/j.bja.2025.04.001_bib93","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12610","article-title":"Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study","volume":"3","author":"Acosta","year":"2015","journal-title":"Physiol Rep"},{"key":"10.1016\/j.bja.2025.04.001_bib94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.regpep.2008.07.003","article-title":"Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes","volume":"151","author":"Linnebjerg","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.bja.2025.04.001_bib95","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/jdi.13598","article-title":"Effects of glucagon-like peptide-1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: a prospective, observational study","volume":"12","author":"Kuwata","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.bja.2025.04.001_bib96","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2337\/dc20-0720","article-title":"Effects of lixisenatide versus liraglutide (short- and long-acting GLP-1 receptor agonists) on esophageal and gastric function in patients with type 2 diabetes","volume":"43","author":"Quast","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bja.2025.04.001_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2013.04.001","article-title":"Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia","volume":"185","author":"Lorenz","year":"2013","journal-title":"Regul Pept"},{"key":"10.1016\/j.bja.2025.04.001_bib98","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/dom.13935","article-title":"Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal-related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes","volume":"22","author":"Meier","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib99","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc14-1984","article-title":"Contrasting effects of lixisenatide and liraglutide on postprandial glycemic control, gastric emptying, and safety parameters in patients with type 2 diabetes on optimized insulin glargine with or without metformin: a randomized, open-label trial","volume":"38","author":"Meier","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bja.2025.04.001_bib100","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/dom.13956","article-title":"Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrations","volume":"22","author":"Jones","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib101","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/oby.23481","article-title":"Effects of liraglutide on gastrointestinal functions and weight in obesity: a randomized clinical and pharmacogenomic trial","volume":"30","author":"Maselli","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bja.2025.04.001_bib102","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/dom.12133","article-title":"Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial","volume":"15","author":"Hermansen","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib103","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/dom.12247","article-title":"Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes","volume":"16","author":"Nagai","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib104","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","article-title":"Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial","volume":"2","author":"Halawi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.bja.2025.04.001_bib105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.diabet.2017.05.009","article-title":"Effect of GLP-1 receptor agonist on gastrointestinal tract motility and residue rates as evaluated by capsule endoscopy","volume":"43","author":"Nakatani","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib106","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/dom.14944","article-title":"Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity","volume":"25","author":"Jensterle","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib107","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/a-0818-6374","article-title":"Exenatide delays gastric emptying in patients with type 2 diabetes mellitus but not in those with gastroparetic conditions","volume":"51","author":"Beti","year":"2019","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.bja.2025.04.001_bib108","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/dom.13544","article-title":"Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: a randomized crossover trial","volume":"21","author":"Geyer","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib109","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jdi.13115","article-title":"Magnitude of slowing gastric emptying by glucagon-like peptide-1 receptor agonists determines the amelioration of postprandial glucose excursion in Japanese patients with type 2 diabetes","volume":"11","author":"Suganuma","year":"2020","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.bja.2025.04.001_bib110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1463-1326.2011.01364.x","article-title":"A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes","volume":"13","author":"Barrington","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib111","doi-asserted-by":"crossref","first-page":"E846","DOI":"10.1152\/ajpendo.00030.2008","article-title":"Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes","volume":"294","author":"Cervera","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib112","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1210\/jc.2010-2146","article-title":"Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjects","volume":"96","author":"Cersosimo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib113","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1185\/03007990802418851","article-title":"Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study","volume":"24","author":"DeFronzo","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bja.2025.04.001_bib114","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","article-title":"Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study","volume":"372","author":"Drucker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bja.2025.04.001_bib115","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1210\/jc.2003-032001","article-title":"Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes","volume":"89","author":"Dupr\u00e9","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib116","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/dc13-1169","article-title":"Acute metabolic effects of exenatide in patients with type 1 diabetes with and without residual insulin to oral and intravenous glucose challenges","volume":"37","author":"Ghazi","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bja.2025.04.001_bib117","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajhp\/62.2.173","article-title":"Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus","volume":"62","author":"Kolterman","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bja.2025.04.001_bib118","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2337\/diabetes.53.5.1187","article-title":"One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes","volume":"53","author":"Degn","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bja.2025.04.001_bib119","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(15)00436-2","article-title":"Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial","volume":"4","author":"Dejgaard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.bja.2025.04.001_bib120","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1111\/dom.15889","article-title":"Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): a randomized, double-blind, placebo-controlled trial","volume":"26","author":"Dejgaard","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib121","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12325-010-0110-x","article-title":"The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients","volume":"28","author":"Flint","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.bja.2025.04.001_bib122","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/dom.12830","article-title":"Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: a randomized, placebo-controlled, double-blind, parallel-group study","volume":"19","author":"Frandsen","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib123","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.diabres.2012.02.016","article-title":"Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes","volume":"97","author":"Horowitz","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.bja.2025.04.001_bib124","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s12325-011-0044-y","article-title":"The effect of the once-daily human glucagon-like peptide 1 analog liraglutide on the pharmacokinetics of acetaminophen","volume":"28","author":"Kapitza","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.bja.2025.04.001_bib125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/osp4.486","article-title":"Energy intake as a short-term biomarker for weight loss in adults with obesity receiving liraglutide: a randomized trial","volume":"7","author":"Saxena","year":"2021","journal-title":"Obes Sci Pract"},{"key":"10.1016\/j.bja.2025.04.001_bib126","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/HYPERTENSIONAHA.117.10740","article-title":"Lixisenatide versus insulin glulisine on fasting and postbreakfast systemic hemodynamics in type 2 diabetes mellitus patients","volume":"72","author":"Tonneijck","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.bja.2025.04.001_bib127","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ijo.2013.162","article-title":"Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults","volume":"38","author":"van Can","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.bja.2025.04.001_bib128","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/dmrr.2647","article-title":"Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects","volume":"31","author":"Becker","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.bja.2025.04.001_bib129","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/nu12071962","article-title":"Acute effects of lixisenatide on energy intake in healthy subjects and patients with type 2 diabetes: relationship to gastric emptying and intragastric distribution","volume":"12","author":"Jalleh","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bja.2025.04.001_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108793","article-title":"Effect of lixisenatide on liquid gastric emptying in type 2 diabetes - implications for the use of GLP-1 receptor agonists before procedures","volume":"38","author":"Kovoor","year":"2024","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.bja.2025.04.001_bib131","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/dom.13633","article-title":"Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes","volume":"21","author":"Jones","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib132","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00125-020-05158-9","article-title":"The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial","volume":"63","author":"Juel","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.bja.2025.04.001_bib133","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s13300-022-01258-4","article-title":"Acute administration of the GLP-1 receptor agonist lixisenatide diminishes postprandial insulin secretion in healthy subjects but not in type 2 diabetes, associated with slowing of gastric emptying","volume":"13","author":"Marathe","year":"2022","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.bja.2025.04.001_bib134","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2337\/dc20-0190","article-title":"Effects of sustained treatment with lixisenatide on gastric emptying and postprandial glucose metabolism in type 2 diabetes: a randomized controlled trial","volume":"43","author":"Rayner","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bja.2025.04.001_bib135","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/dom.14373","article-title":"Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes","volume":"23","author":"Dahl","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib136","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib137","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/dom.13120","article-title":"Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity","volume":"20","author":"Hjerpsted","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib138","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1111\/dom.15802","article-title":"Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: a randomized controlled trial","volume":"26","author":"Gabe","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib139","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/dom.14110","article-title":"The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists","volume":"22","author":"Urva","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib140","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/ALN.0000000000005204","article-title":"Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: applying evidence to clinical practice","volume":"141","author":"Oprea","year":"2024","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.04.001_bib141","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1530\/EJE-19-0566","article-title":"Management of endocrine disease: are all GLP-1 agonists equal in the treatment of type 2 diabetes?","volume":"181","author":"Nauck","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bja.2025.04.001_bib142","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.bja.2024.10.013","article-title":"Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system","volume":"134","author":"Huang","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.04.001_bib143","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2012.373","article-title":"Clinical guideline: management of gastroparesis","volume":"108","author":"Camilleri","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bja.2025.04.001_bib144","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jcag\/gwac035","article-title":"Preparing for colonoscopy in people with diabetes: a review with suggestions for clinical practice","volume":"6","author":"Chirila","year":"2023","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1016\/j.bja.2025.04.001_bib145","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s10620-013-2715-9","article-title":"Novel and validated approaches for gastric emptying scintigraphy in patients with suspected gastroparesis","volume":"58","author":"Camilleri","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bja.2025.04.001_bib146","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/ALN.0000000000004381","volume":"138","author":"Joshi","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.04.001_bib147","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.14309\/ajg.0000000000002820","article-title":"Quantified metrics of gastric emptying delay by GLP-1 agonists: a systematic review and meta-analysis with insights for periprocedural management","volume":"119","author":"Hiramoto","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bja.2025.04.001_bib148","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1213\/ANE.0000000000006791","article-title":"Society for Ambulatory Anesthesia updated consensus statement on perioperative blood glucose management in adult patients with diabetes mellitus undergoing ambulatory surgery","volume":"139","author":"Rajan","year":"2024","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.04.001_bib149","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1111\/dom.14166","article-title":"Glucagon-like peptide-1 receptor agonists and the appropriate measurement of gastric emptying","volume":"22","author":"Horowitz","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib150","doi-asserted-by":"crossref","first-page":"835","DOI":"10.14444\/8544","article-title":"Preoperative dehydration predicts adverse events following anterior cervical discectomy and fusion","volume":"17","author":"Ghali","year":"2023","journal-title":"Int J Spine Surg"},{"key":"10.1016\/j.bja.2025.04.001_bib151","doi-asserted-by":"crossref","unstructured":"Quan T, Magruder M, Chen FR, Tabaie S, Best MJ, Aiyer A. Preoperative dehydration increases the risk of extended length of hospital stay following total ankle arthroplasty. Foot Ankle Spec Advance Access published on May 11, 2023, doi: 10.1177\/19386400231169367.","DOI":"10.1177\/19386400231169367"},{"key":"10.1016\/j.bja.2025.04.001_bib152","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s11255-018-1901-2","article-title":"Association between preoperative hydration status and acute kidney injury in patients managed surgically for kidney tumours","volume":"50","author":"Ellis","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.bja.2025.04.001_bib153","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.hrtlng.2005.04.002","article-title":"Variables influencing intravenous catheter insertion difficulty and failure: an analysis of 339 intravenous catheter insertions","volume":"34","author":"Jacobson","year":"2005","journal-title":"Heart Lung"},{"key":"10.1016\/j.bja.2025.04.001_bib154","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/ALN.0000000000003343","article-title":"Preoperative fluid fasting times and postinduction low blood pressure in children: a retrospective analysis","volume":"133","author":"Simpao","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.04.001_bib155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13741-023-00320-4","article-title":"A preoperative ultrasound-based protocol for optimisation of fluid therapy to prevent early intraoperative hypotension: a randomised controlled study","volume":"12","author":"Szab\u00f3","year":"2023","journal-title":"Perioper Med (Lond)"},{"key":"10.1016\/j.bja.2025.04.001_bib156","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12891-022-06118-7","article-title":"The impact of dehydration on short-term postoperative complications in total knee arthroplasty","volume":"24","author":"Lung","year":"2023","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.bja.2025.04.001_bib157","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/ALN.0000000000002603","article-title":"Perioperative fluid therapy for major surgery","volume":"130","author":"Miller","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.04.001_bib158","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/jcm12010145","article-title":"Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus","volume":"12","author":"Gorgojo-Mart\u00ednez","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.bja.2025.04.001_bib159","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","article-title":"Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice","volume":"134","author":"Wharton","year":"2022","journal-title":"Postgrad Med"},{"key":"10.1016\/j.bja.2025.04.001_bib160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jamainternmed.2022.0338","article-title":"Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials","volume":"182","author":"He","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.bja.2025.04.001_bib162","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jhm.228","article-title":"Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists","volume":"2","author":"Kripalani","year":"2007","journal-title":"J Hosp Med"},{"key":"10.1016\/j.bja.2025.04.001_bib163","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/dom.14347","article-title":"Liraglutide hospital discharge trial: a randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge","volume":"23","author":"Pasquel","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bja.2025.04.001_bib166","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1464-5491.2012.03582.x","article-title":"NHS Diabetes guideline for the perioperative management of the adult patient with diabetes","volume":"29","author":"Dhatariya","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.bja.2025.04.001_bib167","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bja.2023.12.015","article-title":"Perioperative use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes mellitus","volume":"132","author":"Dhatariya","year":"2024","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.04.001_bib168","first-page":"167","article-title":"5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel","volume":"3","author":"Abou","year":"2009","journal-title":"Gastrointest Cancer Res"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225002144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091225002144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:35:00Z","timestamp":1782952500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091225002144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0007091225002144"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2025.04.001","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}